Wall Street Analysts Predict a 45.04% Upside in Exact Sciences (EXAS): Here's What You Should Know

Shares of Exact Sciences (EXAS) have gained 23.4% over the past four weeks to close the last trading session at $55.77, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $80.89 indicates a potential upside of 45%.The mean estimate comprises 19 short-term price targets with a standard deviation of $9.28. While the lowest estimate of $66 indicates an 18.3% increase from the current ...